Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years

Stefania La Grutta, Franco Frati, Stefania La Grutta, Laura Sensi, Giovanbattista Pajno, Cristoforo Incorvaia, Francesco Marcucci, Alessandro Fiocchi, Francesco Pezzuto

    Research output: Contribution to journalArticlepeer-review

    107 Citations (Scopus)

    Abstract

    The minimum age to start specific immunotherapy with inhalant allergens in children has not been clearly established, and position papers discourage its use in children younger than 5 years.
    Original languageEnglish
    Pages (from-to)254-258
    Number of pages5
    JournalANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    Volume95
    Publication statusPublished - 2005

    All Science Journal Classification (ASJC) codes

    • Immunology and Allergy
    • Immunology
    • Pulmonary and Respiratory Medicine

    Fingerprint

    Dive into the research topics of 'Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years'. Together they form a unique fingerprint.

    Cite this